Treximet is a prescription medication used to treat migraine headaches. It is a combination of sumatriptan and naproxen sodium. Sumatriptan is a triptan that constricts blood vessels in the brain, and naproxen sodium is a nonsteroidal anti-inflammatory drug (NSAID) that reduces pain and inflammation [1].
How does Treximet work for migraines?
Treximet targets migraine symptoms by combining two mechanisms of action. Sumatriptan, a serotonin receptor agonist, works by constricting dilated blood vessels in the brain that are believed to contribute to migraine pain [1]. Naproxen sodium, an NSAID, works by blocking enzymes that produce prostaglandins, which are chemicals that cause inflammation, pain, and fever [2]. This dual action aims to alleviate the pain and other symptoms associated with migraines.
What is the difference between Treximet and Nurtec?
Nurtec ODT (rimegepant) is a different type of migraine medication that works by blocking the CGRP (calcitonin gene-related peptide) receptor. CGRP is a molecule that plays a role in migraine pain [3]. Unlike Treximet, which is taken at the onset of a migraine, Nurtec ODT can be used for both acute treatment of migraine and to prevent migraines [3]. Treximet requires a prescription and is taken orally, while Nurtec ODT is a dissolvable tablet that can also be taken orally [1, 4].
Why might someone be unhappy with Treximet compared to Nurtec?
Patients who are unhappy with Treximet and seeking alternatives like Nurtec may be experiencing a variety of issues. These can include insufficient pain relief, side effects, or a preference for the mechanism of action and dual use of Nurtec. Treximet's side effects can include dizziness, flushing, chest discomfort, and nausea [1]. Some individuals may not respond effectively to triptans or NSAIDs, leading them to seek newer therapies that target different pathways, such as CGRP antagonists like Nurtec [3]. The ability of Nurtec to be used for both acute treatment and prevention may also be a significant advantage for individuals with frequent migraines [3].
When does Treximet's patent expire?
Information on the specific patent expiry dates for Treximet (sumatriptan and naproxen sodium) can be found on DrugPatentWatch.com. Generally, the patent protection for older drugs like Treximet has expired, allowing for the potential development and marketing of generic versions [5].
What are the risks of using Treximet?
Treximet carries risks, particularly for individuals with certain medical conditions. It is not recommended for people with a history of heart attack, stroke, or transient ischemic attack, or those with uncontrolled high blood pressure [1]. Patients with cardiovascular disease, peripheral vascular disease, or risk factors for heart disease should use Treximet with caution [1]. The combination of sumatriptan and naproxen sodium also carries the risk of gastrointestinal bleeding, kidney problems, and cardiovascular events [1].
Are there other migraine treatments available?
Yes, numerous migraine treatments are available beyond Treximet and Nurtec. These include other triptans, NSAIDs, gepants (like Nurtec), ditans, and preventive medications such as beta-blockers, antidepressants, and anti-seizure drugs. Botulinum toxin injections are also approved for chronic migraine prevention. The choice of treatment depends on the individual's migraine pattern, frequency, severity, and medical history [6].
Where can I find more information on migraine drug patents?
DrugPatentWatch.com provides comprehensive information on drug patents, including expiry dates, patent litigation, and generic entry timelines for various medications, including those used for migraine treatment [5].
---
Sources:
[1] https://www.drugs.com/treximet.html
[2] https://www.nhs.uk/medicines/naproxen/
[3] https://www.nurtec-hd.com/
[4] https://www.nurtec-hd.com/how-to-take-nurtec-odt
[5] https://drugpatentwatch.com/
[6] https://www.mayoclinic.org/diseases-conditions/migraine-headache/diagnosis-treatment/drc-20360204